22 results match your criteria: "Carcinogenesis Institute[Affiliation]"
Cancers (Basel)
March 2024
Carcinogenesis Institute, N.N. Blokhin National Medical Research Oncology Center, The Ministry of Health of Russia, 115478 Moscow, Russia.
Cancer cell aggressiveness, marked by actin cytoskeleton reconfiguration critical for metastasis, may result from an imbalanced ratio favoring γ-actin. Dysfunctional p53 emerges as a key regulator of invasiveness and migration in various cancer cells, both in vitro and in vivo. P53 inactivation (via mutants R175H, R248W, R273H, or TP53 repression) significantly enhanced the migration, invasion, and proliferation of human lung adenocarcinoma A549 cells in vitro and in vivo, facilitating intrapulmonary xenograft metastasis in athymic mice.
View Article and Find Full Text PDFCancers (Basel)
November 2023
Biomarker Research Laboratory, Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia.
Diagnostics (Basel)
August 2023
Department of Pathology, Kazan State Medical University, Kazan 420012, Russia.
Aim: To establish a p53-negative osteosarcoma (OS) SaOS-2 cellular subline exhibiting resistance to specific chemotherapeutic agents, including topoisomerase II inhibitors, taxanes, and vinca alkaloids.
Methods: The OS subline exhibiting resistance to the chemotherapeutic agents indicated above was generated by the stepwise treatment of the parental SaOS-2 cell line with increasing concentrations of doxorubicin (Dox) for 5 months. Half-inhibitory concentrations (IC) for Dox, vinblastine (Vin), and paclitaxel (PTX) were calculated by a colorimetric MTS-based assay.
Molecules
September 2021
Cytogenetics Laboratory, Carcinogenesis Institute, N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia.
Microtubule targeting agents (MTAs) that interfere with the dynamic state of the mitotic spindle are well-known and effective chemotherapeutic agents. These agents interrupt the microtubule network via polymerization or depolymerization, halting the cell cycle progression and leading to apoptosis. We report two novel pyrrole-based carboxamides (CAs) (CA-61 and -84) as the compounds exhibiting potent anti-cancer properties against a broad spectrum of epithelial cancer cell lines, including breast, lung, and prostate cancer.
View Article and Find Full Text PDFCancers (Basel)
June 2020
Cytogenetics Laboratory, Carcinogenesis Institute, N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia.
Inhibition of KIT-signaling is a major molecular target for gastrointestinal stromal tumor (GIST) therapy, and imatinib mesylate (IM) is known as the most effective first-line treatment option for patients with advanced, unresectable, and/or metastatic GISTs. We show here for the first time that the inhibition of KIT-signaling in GISTs induces profound changes in the cellular secretome, leading to the release of multiple chemokines, including FGF-2. IM increased migration, invasion, and colony formation of IM-resistant GISTs in an FGF2-dependent manner, whereas the use of blocking anti-FGF2 antibodies or BGJ398, a selective FGFR inhibitor, abolished these effects, thus suggesting that the activation of FGF2-mediated signaling could serve as a compensatory mechanism of KIT-signaling inhibited in GISTs.
View Article and Find Full Text PDFAnticancer Drugs
June 2019
Cytogenetics Laboratory, Carcinogenesis Institute, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia.
We showed recently that ethyl-2-amino-pyrrole-3-carboxylates (EAPCs) exhibit potent antiproliferative activities against a broad spectrum of soft tissue sarcoma and gastrointestinal stromal tumor (GIST) cell lines in vitro. The molecular mechanism of action was owing to inhibition of tubulin polymerization and induction of a robust G2/M cell-cycle arrest, leading to the accumulation of tumor cells in the M-phase and induction of apoptosis. Given that more than 50% of the patients with GISTs develop resistance to imatinib (IM) over the 2 years of IM-based therapy, we examined whether EAPCs exhibit activity against IM-resistant GISTs in vitro and in vivo.
View Article and Find Full Text PDFClin Cancer Res
February 2018
Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, New York.
Breast cancer is among the leading causes of cancer-related death; discovery of novel prognostic markers is needed to improve outcomes. Combining systems biology and epidemiology, we investigated miRNA-associated genes and breast cancer survival in a well-characterized population-based study. A recently developed algorithm, , was used to identify key miRNA "activities" corresponding to target gene degradation, which were predictive of breast cancer mortality in published databases.
View Article and Find Full Text PDFJ Extracell Vesicles
May 2015
Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia.
Appl Immunohistochem Mol Morphol
April 2015
*Laboratory for Biological Microchips, Engelhardt Institute of Molecular Biology of Russian Academy of Sciences †Laboratory for Clinical Oncogenetics, Clinical Oncology Research Institute ‡Laboratory for Cellular and Viral Oncogene Regulation, Carcinogenesis Institute §Oncogenomics Laboratory, Carcinogenesis Institute, N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences ∥Laboratory of Molecular Biology, Moscow City Oncology Hospital #62 of Moscow Healthcare Department, Moscow area, Russian Federation.
Targeted inhibitors of the epidermal growth factor receptor (EGFR) are used for the treatment of non-small cell lung cancer (NSCLC). Somatic mutations in the EGFR gene and key effectors of the EGFR-signaling pathway (KRAS, BRAF, PIK3CA) are associated with sensitivity to these drugs. We developed a highly sensitive LUNG CANCER (LC)-biochip approach for the detection of the most common EGFR, KRAS, PIK3CA, and BRAF gene mutations.
View Article and Find Full Text PDFJ Immunotoxicol
October 2014
Laboratory of Regulatory Mechanisms in Immunity, Carcinogenesis Institute, N. N. Blokhin Cancer Research Center, RAMS, Moscow , Russia.
The concept of immunological surveillance implies that immunogenic variants of tumor cells arising in the organism can be recognized by the immune system. Tumor progression is provided by somatic evolution of tumor cells under the pressure of the immune system. The loss of MHC Class I molecules on the surface of tumor cells is one of the most known outcomes of immune selection.
View Article and Find Full Text PDFPLoS One
June 2014
Epigenetics Unit, International Agency for Research on Cancer (IARC), Lyon, France ; Carcinogenesis Institute of N.N Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia.
Lung cancer is the major human malignancy, accounting for 30% of all cancer-related deaths worldwide. Poor survival of lung cancer patients, together with late diagnosis and resistance to classic chemotherapy, highlights the need for identification of new biomarkers for early detection. Among different cancer biomarkers, small non-coding RNAs called microRNAs (miRNAs) are considered the most promising, owing to their remarkable stability, their cancer-type specificity, and their presence in body fluids.
View Article and Find Full Text PDFJ Immunotoxicol
October 2008
N. N. Blokhin's Cancer Research Center, Carcinogenesis Institute, Moscow, Russia.
Discovery of major histocompatability complex (MHC) restriction helped in the understanding of how T-lymphocytes recognize antigens on bacteria, viruses, and tumor cells. It was initially accepted that MHC restriction was a consequence of "adaptive differentiation" in the thymus; during differentiation, the forming repertoire of T-lymphocytes "learned" a low affinity for self MHC molecules via positive selection. This view was later countered by discovery of artifacts in underlying studies and the fact that adaptive differentiation could not explain direct allogeneic and allorestricted recognition phenomena.
View Article and Find Full Text PDFPurpose/Method. Transfection experiments have been used to identify activated oncogenes in a wide variety of tumour types. Here we describe the use of transfection experiments utilizing DNA from a human pleomorphic liposarcoma to identify a novel gene, designated lip which maps to chromosome 19.
View Article and Find Full Text PDFCell Immunol
September 2007
Laboratory of Regulatory Mechanisms in Immunity, Carcinogenesis Institute State Institution Russian N.N. Blokhin Cancer Research Center Russian Academy of Medical Sciences, Kashirskoe shosse 24, 115478 Moscow, Russia.
Supernatant obtained from high dose hydrocortisone resistant thymocytes can induce migration of the bone marrow cell precursors to the periphery. This biological activity depends on the presence of the 18 kDa protein, whose amino acid sequence fits with the sequence of the secretory form of murine cyclophilin A (SP-18). Cyclophilin A isolated from the supernatant of the cortisone-resistant thymoma EL-4 shows its characteristic functional features as it demonstrates isomerase activity and binds with cyclosporine A.
View Article and Find Full Text PDFHum Mutat
February 2004
Genomic Disorders Research Centre, Daly Wing, St. Vincent's Hospital, Melbourne, Victoria, Australia.
Mutations in the tumor-suppressor p53 gene TP53 are frequent in most human cancers including breast cancer. A new solid phase chemical cleavage of mismatch method (CCM) allowed rapid and efficient screening and analysis of the TP53 gene in DNA samples extracted from tumors of 89 breast cancer patients. The novel CCM technique utilized silica beads and the potassium permanganate/tetraethylammonium chloride (KMnO(4)/TEAC) and hydroxylamine (NH(2)OH) reactions were performed sequentially in a single tube.
View Article and Find Full Text PDFZhonghua Zhong Liu Za Zhi
May 2002
Chemical Carcinogenesis Institute, Guangzhou Medical College, Guangzhou 510182, China.
Objective: To clone differentially expressed cDNA sequences involved in malignant transformation induced by benzo(a)pyrene metabolite dihydroxyepoxy benzo pyrene (BPDE).
Method: The malignant transformation of human bronchial epithelial cell line 16HBE induced by BPDE in vitro was used as a model for comparing gene expression between the transformed cells and controls. cDNA representational difference analysis (cDNA-RDA) was performed to isolate differentially expressed cDNA fragment in transformed cells.
Eur J Biochem
January 2001
Carcinogenesis Institute, Cancer Research Centre, Russian Academy of Medical Sciences, Moscow, Russia.
Interaction of linear homologous DNA duplexes by formation of Holliday junctions was revealed by electrophoresis and confirmed by electron microscopy. The phenomenon was demonstrated using a model of five purified PCR products of different size and sequence. The double-stranded structure of interacting DNA fragments was confirmed using several consecutive purifications, S1-nuclease analysis, and electron microscopy.
View Article and Find Full Text PDFSarcoma
July 2011
Section of Molecular Carcinogenesis Institute of Cancer Research Haddow Laboratories 15 Downs Road, Belmont, Sutton Surrey SM2 5NG UK.
Purpose. Amplification of genetic sequences on chromosome 12q13 is frequently found in soft tissue tumours. However, for the MDM2 gene, over-expression of the MDM2 protein has not always been shown to accompany gene amplification, raising the possibility that amplification of genetic sequences targets alternative genes on chromosome 12q13 for over-expression.
View Article and Find Full Text PDFImmunology
October 1995
Laboratory of Regulatory Mechanisms in Immunity, Carcinogenesis Institute, Cancer Research Centre, Moscow, Russia.
Six individual peptides of the major histocompatibility complex (MHC) class I molecule H-2Kb were synthesized. Intravenous injection of peptide 6 into mice prolonged the survival of Kb (BL/6 or B10.MBR) skin grafts on allogeneic R101 and B10.
View Article and Find Full Text PDFWe have defined a tissue culture method suitable to study cell-cell interactions in an environmental set close to in vivo conditions. It consists of heterotypic cell populations mixed together inside a collagen gel in a chamber slide for a period of up to 14 days. When the three-dimensional system is saturated, cells will start to move on the plastic surface as monolayers surrounding the gel, with a characteristic speed depending on cell type.
View Article and Find Full Text PDFImmunol Lett
September 1990
Carcinogenesis Institute, All-Union Cancer Research Center, Moscow, U.S.S.R.
The in vivo-induced pCTL-2 cells of the L3T4- Lyt-2+ phenotype specific for the H-2Kb molecule are converted into effector CTLs in mixed lymphocyte culture (MLC) in the presence of heat-treated donor stimulators much more efficiently when the donor and recipient differ from each other, not only in the major histocompatibility complex (MHC) class I (H-2Kb) (anti-B10.MBR B10.AKM) but also in the MHC classes I + II, i.
View Article and Find Full Text PDFRes Immunol
January 1990
Laboratory of Regulatory Immunity Mechanisms, Carcinogenesis Institute, Cancer Research Center, All-Union Moscow.
The fine specificity of antigen-binding receptors was compared in pCTL-2 and secondary effector CTL (cytotoxic T lymphocytes) induced in vivo with the H-2Kb alloantigen in recombinant inbred mice. The lymphocyte preparations were enriched by elution from macrophage monolayers of various origins, including the donor (B6 strain), the H-2Kb mutant bm1, the H-2Kk allele B10.A(4R) and the recipient strain B10.
View Article and Find Full Text PDF